Making a Case for Employing a Societal Perspective in the Evaluation of Medicaid Prescription Drug Interventions

January 2009
Journal of Teaching in Physical Education;Jan2009, Vol. 28 Issue 1, p281
Academic Journal
No abstract available.


Related Articles

  • Making a Case for Employing a Societal Perspective in the Evaluation of Medicaid Prescription Drug Interventions. Roy, Sanjoy; Madhavan, S. Suresh // PharmacoEconomics;2008, Vol. 26 Issue 4, p281 

    The choice of a perspective is among the most critical influences of the potential outcome of an economic evaluation, since it determines whose interest is relevant in any given analysis. For publicly funded programmes such as Medicaid, and now Medicare, it is important that economic evaluations...

  • Medicare drug proposal may help employers qualify for tax break. Geisel, Jerry // Business Insurance;8/2/2004, Vol. 38 Issue 31, p3 

    Proposed federal regulations could make it easier for some employers that retain prescription drug coverage for their retirees to collect a rich government subsidy. The regulations, proposed last week by the Centers for Medicare and Medicaid Services, involve the 2003 federal law that, starting...

  • Promoting Health Care Consumerism.  // HR Magazine;Dec2011, Vol. 56 Issue 12, p76 

    The article discusses health care consumerism in the U.S. from the perspective that employers are trying to control their health care and prescription drug benefit costs. The discussion focuses on incentives to make employees more aware of costs related to health care services and prescription...

  • Surveillance for isocyanate asthma: a model based cost effectiveness analysis. Wild, D. M.; Redlich, C. A.; Paltiel, A. D. // Occupational & Environmental Medicine;Nov2005, Vol. 62 Issue 11, p743 

    Aims: Because logistical and financial obstacles impede using large prospective cohort studies, surveillance decisions in occupational settings must often be made without evidence of relative benefits and costs. Using the example of isocyanate induced asthma, the most commonly reported immune...

  • Guidance eases compliance with Medicare notification rule. Geisel, Jerry // Business Insurance;6/6/2005, Vol. 39 Issue 23, p4 

    The article reports on a federal guidance released recently by the U.S. Centers for Medicare and Medicaid Services. This will make it easier for employers to comply with a requirement that they notify Medicare-eligible employees and retirees about how their group prescription drug coverage...

  • Economic effects of clinical pharmacy interventions: A literature review. de Rijdt, Thomas; Willems, Ludo; Simoens, Steven // American Journal of Health-System Pharmacy;6/15/2008, Vol. 65 Issue 12, p1161 

    Purpose. Economic evaluations of clinical pharmacy interventions are reviewed. Summary. A variety of clinical pharmacy interventions have been assessed, but the body of evidence relating to any particular type of intervention is small. Cost-saving interventions comprise a small percentage of...

  • Supreme Court approves Maine's drug discount plan. Lenckus, Dave // Business Insurance;5/26/2003, Vol. 37 Issue 21, p1 

    In tentatively approving Maine's discount prescription drug program, the U.S. Supreme Court has set up employer-sponsored health plans as vehicles to subsidize the cost of prescription drugs for the poor and uninsured, business and pharmaceutical representatives. With numerous other states...

  • MISSOURI'S EXPERIMENT. Byrd, John E.; Parks, Joseph; Oestreich, George; Surles, Richard // Behavioral Healthcare;Feb2006, Vol. 26 Issue 2, p12 

    Reveals that prescription medications to treat psychiatric conditions are among the most costly drugs for Medicaid programs. Factors attributed to the growth of expenditures for drugs; Cost of antidepressants and antipsychotics; Reason prescription drugs' costs and the overall Medicaid...

  • Retiree Drug Coverage Comes Up for Renewal. Babcock, Pamela // HR Magazine;Sep2006, Vol. 51 Issue 9, p54 

    This article reports on a need for companies that offer prescription drug benefits to retirees to make a decision on whether to continue providing that benefit for 2007 if they do not want to miss out on the tax-free federal subsidies they can get for providing retiree drug coverage. To qualify...

  • A Primer on Prescription Drug Abuse and the Role of the Pharmacy Director. Haruin, Andre; Weber, Robert J. // Hospital Pharmacy;May2015, Vol. 50 Issue 5, p423 

    Prescription drug abuse, or using a prescription drug in a way not intended by the provider, has become such an issue in the United States that in 2013 the US Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) classified it as a new epidemic....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics